Clinical Trials
34 trialsE-FACTOR
Centre Leon Berard
CONVERCAP
Institut Bergonié
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
LAPC
EBG MedAustron GmbH
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
AdventHealth
B-GLUCANCER2
Poitiers University Hospital
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Memorial Sloan Kettering Cancer Center
ICAPAC
University Hospital, Toulouse
METEOR-CRATR
Washington University School of Medicine
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
Rigshospitalet, Denmark
SERPAN
Centre Hospitalier Universitaire de Saint Etienne
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang University
PREVENPANC
Hospital Clinic of Barcelona
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Washington University School of Medicine
EUS-CTC
Institut Paoli-Calmettes
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
Seoul National University Hospital
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
Seoul National University Hospital
IMMUNOPANC
Institut Paoli-Calmettes
ONCOPRO
Hospices Civils de Lyon
Circulating Epigenetics in Pancreatic Surgery
Rigshospitalet, Denmark
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
Poitiers University Hospital
Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities
Yonsei University
BAT-Cachexia
Maastricht University Medical Center
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
SPORE-PANC
University of Michigan
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Memorial Sloan Kettering Cancer Center
MEN1
Jersey Shore University Medical Center
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Ghrelin Levels in Pancreatic Cancer Patients
Dartmouth-Hitchcock Medical Center
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Depression, Cytokines and Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Stanford University